About Autotelic

About company

Autotelic uses therapeutic drug monitoring to enhance the development of therapeutics. It is designed to Increase patent life, expand the therapeutic window, and shorten the clinical development path. Autotelic starts companies or invest in existing companies combining our TDM device with the licensed therapeutics to become a winning drug-device combination. It brings on experts and the experience needed for a successful biotechnology/pharma company. They take company through its logical exit points either M&A or to access the public markets so that sufficient funding is in place to fully develop the drug-device combination.